Related references
Note: Only part of the references are listed.Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
D. Gaudet et al.
GENE THERAPY (2013)
Regulatory evaluation of Glybera in Europe - two committees, one mission
Daniela Melchiorri et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Lessons Learned from the Clinical Development and Market Authorization of Glybera
Laura M. Bryant et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2013)
Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver
Ali Nowrouzi et al.
MOLECULAR THERAPY (2012)
Specific Micro RNA-Regulated TetR-KRAB Transcriptional Control of Transgene Expression in Viral Vector-Transduced Cells
Virginie Pichard et al.
PLOS ONE (2012)
Lack of Immunotoxicity After Regional Intravenous (RI) Delivery of rAAV to Nonhuman Primate Skeletal Muscle
Alice Toromanoff et al.
MOLECULAR THERAPY (2010)
Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes
J. Marquis et al.
GENE THERAPY (2009)
Regulation of Episomal Gene Expression by KRAB/KAP1-Mediated Histone Modifications
Isabelle Barde et al.
JOURNAL OF VIROLOGY (2009)
Transduction Efficiency and Immune Response Associated With the Administration of AAV8 Vector Into Dog Skeletal Muscle
Sachiko Ohshima et al.
MOLECULAR THERAPY (2009)
The zinc finger DNA-binding domain of K-RBP plays an important role in regulating Kaposi's sarcoma-associated herpesvirus RTA-mediated gene expression
Zhilong Yang et al.
VIROLOGY (2009)
Adeno-associated virus vector Genomes persist as episomal chromatin in primate muscle
Magalie Penaud-Budloo et al.
JOURNAL OF VIROLOGY (2008)
Safety and efficacy of regional intravenous (RI) versus intramuscular (IM) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle
Alice Toromanoff et al.
MOLECULAR THERAPY (2008)
Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases
K. Stieger et al.
GENE THERAPY (2007)
KRAB can repress lentivirus proviral transcription independently of integration site
Yannick Bulliard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Regulatable gene expression systems for gene therapy
Nuria Vilaboa et al.
CURRENT GENE THERAPY (2006)
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid
Luk H. Vandenberghe et al.
NATURE MEDICINE (2006)
Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors
Knut Stieger et al.
MOLECULAR THERAPY (2006)
A versatile tool for conditional gene expression and knockdown
J Szulc et al.
NATURE METHODS (2006)
Major role of local immune responses in antibody formation to factor IX in AAV gene transfer
L Wang et al.
GENE THERAPY (2005)
Long-term pharmacologically regulated expression of erythropoietin in,primates following AAV-mediated gene transfer
VM Rivera et al.
BLOOD (2005)
Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates
C Lebherz et al.
HUMAN GENE THERAPY (2005)
Gene therapy progress and prospects: transcription regulatory systems
C Toniatti et al.
GENE THERAPY (2004)
Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle
P Chenuaud et al.
MOLECULAR THERAPY (2004)
HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system
F Ginhoux et al.
MOLECULAR THERAPY (2004)
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
VR Arruda et al.
BLOOD (2004)
Conditional suppression of cellular genes: Lentivirus vector-mediated drug-inducible RNA interference
M Wiznerowicz et al.
JOURNAL OF VIROLOGY (2003)
Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery
M Weber et al.
MOLECULAR THERAPY (2003)
Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector
S Folliot et al.
JOURNAL OF GENE MEDICINE (2003)
Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus
D Favre et al.
JOURNAL OF VIROLOGY (2002)
Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression
M Latta-Mahieu et al.
HUMAN GENE THERAPY (2002)
Adeno-associated virus vectors for gene therapy: more pros than cons?
PE Monahan et al.
MOLECULAR MEDICINE TODAY (2000)
Share Paper
